Form 4: Sanara MedTech CEO's Routine Tax Withholding on Stock Vesting

Sanara MedTech CEO Seth Yon's Form 4 filing details the withholding of 873 shares of common stock to cover tax obligations related to restricted stock vesting.

Summary

• Reporting Person: Seth D. Yon, Chief Executive Officer and Director of Sanara MedTech Inc. (SMTI).
• Transaction Date: February 25, 2026.
• Transaction Type: Shares withheld by the Issuer to satisfy tax withholding obligations (Code 'F').
• Shares Withheld: 873 shares of common stock.
• Per-Share Value: $19.9, reflecting the price per share on the vesting date as reported on the Nasdaq Capital Market.
• Underlying Event: The withholding was in connection with the annual vesting of 3,049 previously granted restricted stock shares.
• No shares were issued or sold by the reporting person in this transaction.
• Post-Transaction Ownership: Seth D. Yon beneficially owns 88,978 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting the routine vesting of executive compensation and tax obligations, rather than a discretionary insider sale, which can be seen as a positive for executive retention.

Positives

• The vesting of restricted stock indicates continued compensation and retention of a key executive, Seth D. Yon.
• The transaction is a tax withholding, not a discretionary sale by the CEO, suggesting no change in insider sentiment regarding the company's prospects.

Negatives

• No direct negatives identified as this is a routine tax withholding transaction.

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

StockSavvy.ai notes that routine tax withholdings related to restricted stock vesting are common practice for executive compensation across various industries and do not typically signal a change in company fundamentals or executive sentiment. This is a standard administrative event in executive compensation packages.

Comparison to Industry Standards

• Tax withholding for restricted stock vesting is a standard practice for executive compensation across publicly traded companies, aligning with typical industry benchmarks for managing equity awards.
• The per-share value of $19.9 reflects the market price on the vesting date, which is a common and transparent method for valuing such transactions in executive compensation.

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine administrative transaction related to executive compensation. It confirms the ongoing structure of executive equity awards.
• Employees: Confirms standard executive compensation practices, which can be a positive for morale and retention of key personnel.

Next Steps

• NA

Key Dates

Recommendation

This Form 4 details a routine tax withholding transaction related to the vesting of restricted stock for Sanara MedTech's CEO. It does not indicate any discretionary buying or selling by the insider, nor does it provide new information regarding the company's operational or financial performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Sanara MedTech, SMTI, Form 4, insider transaction, stock vesting, tax withholding, Seth D. Yon, CEO, Director